Sex, age at pacemaker implantation, electrocardiographic indications for implantation, symptoms requiring pacing, and pacing modes employed were recorded. These results were compared with published world data for 1986.2 RESULTS Only first time implantations are considered. The total number of pacemakers implanted over the ten year period in both centres was 1935, with the greater proportion in the Royal Victoria Hospital (63 %). The numbers implanted annually increased from 87 in 1979 to 290 in 1988 ( Table 1 Less definite symptoms such as bradycardia alone have decreased over the ten year period from 18 % to 6 %. These three symptoms have consistently accounted for more than 75% of those implanted, but their proportion has decreased as other indications, such as pacing for tachycardia have increased.
Pacing modes This is the area where there has been the greatest change over the ten year period. In 1979 single chamber ventricular demand pacing was the predominant mode of pacing and accounted for 87% of the total, the other two modes used being atrioventricular sequential (DVI) and atrial demand (AAI).
Over the period the frequency of these three modes of pacing reduced and this was associated with the development and use of other more sophisticated modes of pacing -two more dual chamber modes (DDD and DDI), rate responsive pacing (VVIR) and antitachycardia pacing (Table 11) . The implantation rate in Northern Ireland and throughout the UK is much lower than in many countries throughout the world. The most recent figures available are for 1986, when most western European and North American countries were implanting more than 200 per million, and some countries more than 400 per million population.2 The reasons for these differences in implantation rates are not clear. Possible explanations are a lower prevalence of conditions requiring pacemaker implantation in the UK, underdiagnosis or undertreatment of conditions requiring pacing, or overimplantation in other countries. The high rate of bradycardia as a symptom and sinus node disease as an indication for pacing in some countries with high implantation rates may reflect inappropriate pacing of asymptomatic patients with sinus node disease. It was suggested in 1984 that too many pacemakers were being implanted in the USA.11 This resulted in the introduction of stricter criteria for pacemaker implantation and was followed by a reduction in the implantation rate in that country from 518 per million in 1981 to 359 per million in 1986. This figure is still over twice that of the UK for that year. A reason for the lower implantation rate in the UK may be a different prevalence of conditions requiring pacing. Shaw and Kekwick12 carried out an eight year survey in the Devon area in which they asked general practitioners to report patients who they thought had abnormal bradycardias. They included complete heart block and sinus node disease as indications for pacemaker implantation and found an incidence of complete heart block of 97 per million and symptomatic sinus node disease of 77 per million, a total rate of 174 patients per million requiring pacemaker implantation per year for these conditions. In Northern Ireland in 1988 the implantation rate was 20 per million for second degree heart block, 15 per million for atrial fibrillation and bradycardia, 10 per million for carotid sinus hypersensitivity, 3 per million for bundle branch block and 20 per million for other indications. Taken with the 174 per million estimated by Shaw and Kekwick for complete heart block and sinus node disease, this would suggest that a total implantation rate of 250-300 per million would be more appropriate. Thus the discrepancy between the implantation rates in the UK and other countries may be due to a degree of overtreatment in those countries, but it also seems that there is undertreatment of patients with conditions requiring a permanent pacemaker in the UK. Examination of data from Northern Ireland may suggest reasons why this should be so. Prior to 1983 pacing in Northern Ireland was performed predominantly in one centre, the Royal Victoria Hospital, where 143 implants were performed in 1982. In that year only 35 implants were performed in the Belfast City Hospital. However, over the next five years the number of implantations in the latter hospital increased to 153 in 1988, but there has not been any reduction in the numbers implanted in the RVH. This would suggest that the implantation rates reflect the number of centres performing implantation, greater availability of a pacing service resulting in a greater referral for pacing. It may be that the UK practice of implanting pacemakers in regional centres specialising in pacing gives rise to lower referral rates for investigation and treatment of bradycardias and syncope than if pacing were to be performed in district general hospitals. It has been suggested that the higher implantation rate in the USA may be due to the widespread availability of a pacing centre in almost every community hospital. 13 Fewer ventricular demand pacemakers are implanted in Northern Ireland than in the UK or any other country, but more atrial demand and dual chamber pacemakers are used. The high implantation rate for these latter types of pacemakers probably reflects the fact that in Northern Ireland pacing is carried out in two specialised cardiology units with particular interests in pacing.
